Wellington Management Group LLP Takes Position in Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Wellington Management Group LLP purchased a new stake in shares of Guardian Pharmacy Services, Inc. (NYSE:GRDN - Free Report) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm purchased 500,000 shares of the company's stock, valued at approximately $8,400,000. Wellington Management Group LLP owned approximately 0.81% of Guardian Pharmacy Services at the end of the most recent quarter.

Several other institutional investors and hedge funds have also modified their holdings of the business. Stephens Inc. AR bought a new stake in Guardian Pharmacy Services during the third quarter worth approximately $189,000. Point72 DIFC Ltd bought a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth $573,000. Royce & Associates LP bought a new stake in shares of Guardian Pharmacy Services during the 3rd quarter worth $1,260,000. Foundry Partners LLC acquired a new position in Guardian Pharmacy Services in the 3rd quarter valued at $1,680,000. Finally, Seven Grand Managers LLC bought a new position in Guardian Pharmacy Services in the 3rd quarter worth $2,515,000.

Insider Activity

In related news, Director Thomas J. Salentine, Jr. acquired 35,714 shares of the stock in a transaction dated Friday, September 27th. The shares were bought at an average cost of $14.00 per share, for a total transaction of $499,996.00. Following the purchase, the director now owns 35,714 shares in the company, valued at approximately $499,996. This trade represents a ∞ increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, Director Steven D. Cosler bought 7,000 shares of the company's stock in a transaction dated Tuesday, November 19th. The stock was bought at an average cost of $21.22 per share, with a total value of $148,540.00. Following the completion of the acquisition, the director now owns 17,713 shares in the company, valued at $375,869.86. This represents a 65.34 % increase in their position. The disclosure for this purchase can be found here.

Guardian Pharmacy Services Price Performance

Guardian Pharmacy Services stock traded down $0.95 during mid-day trading on Monday, reaching $22.30. The company had a trading volume of 219,816 shares, compared to its average volume of 158,677. The stock's 50 day simple moving average is $20.85. Guardian Pharmacy Services, Inc. has a 52 week low of $14.16 and a 52 week high of $25.74.

Guardian Pharmacy Services (NYSE:GRDN - Get Free Report) last released its earnings results on Tuesday, November 12th. The company reported ($2.00) earnings per share for the quarter, missing analysts' consensus estimates of $0.19 by ($2.19). The company had revenue of $314.39 million during the quarter, compared to analyst estimates of $303.21 million. Analysts expect that Guardian Pharmacy Services, Inc. will post 0.87 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

GRDN has been the subject of a number of recent analyst reports. Stephens assumed coverage on shares of Guardian Pharmacy Services in a report on Tuesday, October 22nd. They set an "overweight" rating and a $21.00 price target for the company. Truist Financial raised their target price on Guardian Pharmacy Services from $22.00 to $24.00 and gave the company a "buy" rating in a report on Friday, November 15th. Finally, Raymond James started coverage on Guardian Pharmacy Services in a report on Monday, October 21st. They issued an "outperform" rating and a $21.00 target price on the stock.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.